![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
Invesco Solar ETF
TAN
The Technology Select Sector SPDR® Fund
XLK
4
VanEck Semiconductor ETF
SMH
5
United States Natural Gas
UNG
US Stock MarketDetailed Quotes
Achieve Life (ACHV)
- 5.240
- -0.060-1.13%
Close May 29 16:00 ET
- 5.130
- -0.110-2.10%
Post 19:29 ET
537.93MMarket Cap-4.90P/E (TTM)
5.490High5.235Low1.10MVolume5.350Open5.300Prev Close5.85MTurnover1.26%Turnover RatioLossP/E (Static)102.66MShares6.15052wk High50.38P/B457.19MFloat Cap2.00052wk Low--Dividend TTM87.25MShs Float1856247.281Historical High--Div Yield TTM4.81%Range %1.840Historical Low5.327Avg Price1Lot Size
ACHV Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
ACHV Orderflow
Unit: --
ACHV Orderflow Trend
IntradayDayWeekMonth
No Data
Achieve Life (ACHV) News
Achieve Appoints Veteran Banking Executive John Davis as Chief Credit Officer
Achieve Earns Top Ranking for Personal Loan Customer Satisfaction From LendingTree
Achieve Launches $10,000 Debt Payoff Giveaway Through Fresh Start Contest
Analysts Conflicted on These Healthcare Names: InMode (INMD), Achieve Life Sciences (ACHV) and BioNTech SE (BNTX)
Achieve Life Sciences Presents Long-Term Safety Data for Cytisinicline in Smoking Cessation at ATS 2026
Maxim Group Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $10
Achieve Life (ACHV) Stock Forum
$Achieve Life (ACHV.US)$
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
by Globe Newswire
Follow
ORCA-OL data complete the clinical evidence package supporting the cytisinicline smoking cessation NDA
No new safety signals identified by the independent Data Safety Monitoring Committee over 52 weeks of continuous exposure
Nausea — a common barrier to treatment adherence with smoking cessation therapies — was reported in only 2.5% of particip...
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
by Globe Newswire
Follow
ORCA-OL data complete the clinical evidence package supporting the cytisinicline smoking cessation NDA
No new safety signals identified by the independent Data Safety Monitoring Committee over 52 weeks of continuous exposure
Nausea — a common barrier to treatment adherence with smoking cessation therapies — was reported in only 2.5% of particip...
1
1
1
$Achieve Life (ACHV.US)$
Achieve Life Sciences Announces Up to $354 Million Private Placement
by Globe Newswire
Follow
$180 Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval
Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio Partners, Paradigm BioCapital Advisors and Marshall Wace
SEATTLE, Wash. and VANCOUVER, British Columbia, April 16, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, In...
Achieve Life Sciences Announces Up to $354 Million Private Placement
by Globe Newswire
Follow
$180 Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval
Transaction led by Frazier Life Sciences, TPG Life Sciences Innovations, venBio Partners, Paradigm BioCapital Advisors and Marshall Wace
SEATTLE, Wash. and VANCOUVER, British Columbia, April 16, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, In...
2
1
$Achieve Life (ACHV.US)$ Achieve Life Sciences Announces Up to $354M Private Placement! $180 Million Financing Upfront with Up to an Additional $174 Million from Warrants Exercisable Within 20 Days of FDA Approval
Dow Jones
1m
Dow Jones
1m
3
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
JoeTraders : Seems positive, but terrible price action. CRL related perhaps?